Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

890
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
890
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
Lipid Absorption01:24

Lipid Absorption

859
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
859
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

353
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
353
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

298
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
298
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Rumen-derived Prevotella and Megasphaera elsdenii mitigate methane production through functional modulation of rumen microbial metabolism.

Journal of animal science and biotechnology·2026
Same author

Fermented palm kernel cake improves the nutrient degradation of beef cattle by modulating the rumen microbiota.

Frontiers in microbiology·2025
Same author

Functional role of <i>FvMdm10</i> in stress response, pathogenicity, and fumonisins production in <i>fusarium verticillioides</i>.

Virulence·2025
Same author

Unlocking Gut Health: The Potent Role of Stilbenoids in Intestinal Homeostasis.

Animals : an open access journal from MDPI·2025
Same author

Nutritional Value Evaluation and Processing Technology of Feed and Nutrition Regulation Measures for Ruminants.

Animals : an open access journal from MDPI·2024
Same author

Licorice Extract Supplementation Benefits Growth Performance, Blood Biochemistry and Hormones, Immune Antioxidant Status, Hindgut Fecal Microbial Community, and Metabolism in Beef Cattle.

Veterinary sciences·2024

相关实验视频

Updated: Sep 19, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.2K

益生菌和甘油三醇操纵:对于缓解高甘油三醇血症的潜在影响.

Mingliang Zhang1, Weimin Jiang2, Jie Yin1

  • 1College of Animal Science and Technology, Hunan Agriculture University, Changsha 410128, China; Yuelushan Laboratory, Changsha 410128, China.

Journal of advanced research
|June 18, 2025
PubMed
概括

益生菌干预措施通过影响肠道微生物群和宿主脂质代谢,在管理高甘油三糖血症方面表现有前途. 对下一代益生菌的进一步研究可能为这种常见的脂质异常提供新的治疗策略.

关键词:
我们的肠道微生物群.过高甘油三血症是什么意思降低甘油三的作用这是下一代益生菌.

更多相关视频

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.2K

相关实验视频

Last Updated: Sep 19, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.2K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.2K

科学领域:

  • 微生物学 微生物学
  • 代谢障碍 代谢障碍 代谢障碍
  • 胃肠病学 胃肠病学

背景情况:

  • 过高甘油三血是常见的脂质疾病,通常是由遗传和环境因素引起的.
  • 其次性原因包括肥胖,糖尿病,酒精,饮食和某些药物.
  • 通过益生菌调节肠道微生物群是一种降低甘油三水平的潜在策略.

研究的目的:

  • 审查对过高甘油三血症的益生菌干预措施的动物和人类研究.
  • 概述益生菌降低甘油三水平的机制.
  • 探索下一代益生菌的潜力.

主要方法:

  • 最近动物和人类研究的文献综述.
  • 分析涉及肠道微生物群,短链脂肪酸和胆汁酸的机制.
  • 讨论益生菌应用的挑战和前景.

主要成果:

  • 益生菌可以影响肠道脂质吸收和宿主脂质代谢.
  • 特定的益生菌机制涉及代谢物,如短链脂肪酸和胆汁酸.
  • 下一代益生菌可能提供增强的治疗效益.

结论:

  • 肠道微生物群在过高甘油三血症中起着重要作用.
  • 益生菌,特别是下一代菌株,是治疗高甘油三血症的一个有希望的途径.
  • 需要进一步的研究来克服挑战,并实现益生菌的全部潜力.